Table 5 Compliance to DVH constraints as to different prescription dose:
Prescription doses levels | ||||||
|---|---|---|---|---|---|---|
D74 (n = 44 patients) | D76 (n = 40 patients) | D78 (n = 41 patients) | ||||
Rectum | Bladder | Rectum | Bladder | Rectum | Bladder | |
D55 (Gy) | 93.2% (41/44) | 93.2% (41/44) | 90% (36/40) | 100% | 95.1% (39/41) | 100% |
D30 (Gy) | Not evaluated | 100% | Not evaluated | 100% | Not evaluated | 100% |
D25 (Gy) | 97.7% (43/44) | Not evaluated | 100% | Not evaluated | 100% | Not evaluated |
D10 (Gy) | 100% | Not evaluated | 100% | Not evaluated | 100% | Not evaluated |
Dmax (Gy) | 100% | 100% | 97.5% (39/40) | 100% | 100% | 100% |